The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Radiotherapy, Intensity-Modulated

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Radiotherapy, Intensity-Modulated

 

High impact information on Radiotherapy, Intensity-Modulated

 

Chemical compound and disease context of Radiotherapy, Intensity-Modulated

 

Associations of Radiotherapy, Intensity-Modulated with chemical compounds

 

Gene context of Radiotherapy, Intensity-Modulated

 

Analytical, diagnostic and therapeutic context of Radiotherapy, Intensity-Modulated

References

  1. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Koong, A.C., Christofferson, E., Le, Q.T., Goodman, K.A., Ho, A., Kuo, T., Ford, J.M., Fisher, G.A., Greco, R., Norton, J., Yang, G.P. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  2. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device? Teh, B.S., McGary, J.E., Dong, L., Mai, W.Y., Carpenter, L.S., Lu, H.H., Chiu, J.K., Woo, S.Y., Grant, W.H., Butler, E.B. Cancer journal (Sudbury, Mass.) (2002) [Pubmed]
  3. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Kwong, D.L., Sham, J.S., Leung, L.H., Cheng, A.C., Ng, W.M., Kwong, P.W., Lui, W.M., Yau, C.C., Wu, P.M., Wei, W., Au, G. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
  4. Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach. Wiezorek, T., Banz, N., Schwedas, M., Scheithauer, M., Salz, H., Georg, D., Wendt, T.G. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. (2005) [Pubmed]
  5. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Ben-Josef, E., Shields, A.F., Vaishampayan, U., Vaitkevicius, V., El-Rayes, B.F., McDermott, P., Burmeister, J., Bossenberger, T., Philip, P.A. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  6. Evaluation of rapid dose map acquisition of a scanning liquid-filled ionization chamber electronic portal imaging device. Chang, J., Mageras, G.S., Ling, C.C. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  7. The use of electronic portal imaging to verify patient position during intensity-modulated radiotherapy delivered by the dynamic MLC technique. Fielding, A.L., Evans, P.M., Clark, C.H. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  8. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. Crane, C.H., Antolak, J.A., Rosen, I.I., Forster, K.M., Evans, D.B., Janjan, N.A., Charnsangavej, C., Pisters, P.W., Lenzi, R., Papagikos, M.A., Wolff, R.A. International journal of gastrointestinal cancer. (2001) [Pubmed]
  9. Dependence of linac output on the switch rate of an intensity-modulated tomotherapy collimator. Tsai, J.S., Rivard, M.J., Engler, M.J. Medical physics. (2000) [Pubmed]
  10. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. Chua, D.T., Sham, J.S., Au, G.K. Am. J. Clin. Oncol. (2005) [Pubmed]
  11. Metastatic renal cell carcinoma to the nose and ethmoid sinus. Ziari, M., Shen, S., Amato, R.J., Teh, B.S. Urology (2006) [Pubmed]
  12. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours. Seco, J., Clark, C.H., Evans, P.M., Webb, S. The British journal of radiology. (2006) [Pubmed]
  13. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Kam, M.K., Chau, R.M., Suen, J., Choi, P.H., Teo, P.M. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  14. Effect of processing time delay on the dose response of Kodak EDR2 film. Childress, N.L., Rosen, I.I. Medical physics. (2004) [Pubmed]
  15. Validation of intensity modulation on a commercial treatment planning system. Martin, E., Hachem, A., Marcié, S., Hérault, J., Costa, A., Bensadoun, R.J., Lagrange, J.L. Medical physics. (2003) [Pubmed]
  16. Radiation treatment of lung cancer--patterns of practice in Canada. Tai, P., Yu, E., Battista, J., Van Dyk, J. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. (2004) [Pubmed]
  17. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled. Heron, D.E., Gerszten, K., Selvaraj, R.N., King, G.C., Sonnik, D., Gallion, H., Comerci, J., Edwards, R.P., Wu, A., Andrade, R.S., Kalnicki, S. Gynecol. Oncol. (2003) [Pubmed]
  18. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Lee, S.W., Back, G.M., Yi, B.Y., Choi, E.K., Ahn, S.D., Shin, S.S., Kim, J.H., Kim, S.Y., Lee, B.J., Nam, S.Y., Choi, S.H., Kim, S.B., Park, J.H., Lee, K.K., Park, S.H., Kim, J.H. Int. J. Radiat. Oncol. Biol. Phys. (2006) [Pubmed]
 
WikiGenes - Universities